Država: Armenija
Jezik: engleski
Izvor: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում
calcium carbonicum Hahnemanni D6, calcium fluoratum D6, calcium phosphoricum D6, sulfur jodatum D12
Dr. Gustav Klein GmbH & Co. KG
առկա չէ (L03A)
calcium carbonicum Hahnemanni D6, calcium fluoratum D6, calcium phosphoricum D6, sulfur jodatum D12
20mg+ 20mg+ 20mg+ 20mg
tablets
(150) in glass container
OTC
Registered
2021-04-28
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT IMMUNOKIND tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 1 tablet (100 mg) contains: Active substances: Calcium carbonicum Hahnemanni D6 20,00 mg Calcium fluoratum D6 20,00 mg Calcium phosphoricum D6 20,00 mg Sulfur jodatum D12 20,00 mg Excipient with known effect: lactose monohydrate (used as carrier for the homeopathic triturations) For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Tablet. White to almost white, biplane tablet with facet. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS To increase organism’s resistance and for prophylaxis of frequent and recurrent infectious diseases of the upper respiratory tract in infants and children of early age. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology Children up to 6 years of age: 1 tablet is administered 3 times per day. Method of administration Tablets should be allowed to dissolve slowly in the mouth. If necessary, tablets can be dissolved in a little bit of water. An interval of at least half an hour to meals should be kept. 4.3 CONTRAINDICATIONS Hypersensitivity to one of the active substances or to any of the excipients, listed in section 6.1. 4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE This medicinal product contains lactose. Patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption should not take this medicinal product. A reassessment of the therapy is necessary - if the child is poorly responding to IMMUNOKIND, - if additional complaints arise. 2 Parents are advised to consult a doctor if their child is suffering from a thyroid disease before starting the treatment with IMMUNOKIND. Parents are advised not to use IMMUNOKIND for long-term treatment without consultation with a doctor. 4.5 INTERACTION WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF INTERACTION Interactions with other medicinal products have not been observed. The use of this homeopathic medicinal product does not ex Pročitajte cijeli dokument